PE20051157A1 - DIHYDROXYPHENYL-ETHYLAMINE DERIVATIVES AS ß2 AGONISTS - Google Patents

DIHYDROXYPHENYL-ETHYLAMINE DERIVATIVES AS ß2 AGONISTS

Info

Publication number
PE20051157A1
PE20051157A1 PE2005000320A PE2005000320A PE20051157A1 PE 20051157 A1 PE20051157 A1 PE 20051157A1 PE 2005000320 A PE2005000320 A PE 2005000320A PE 2005000320 A PE2005000320 A PE 2005000320A PE 20051157 A1 PE20051157 A1 PE 20051157A1
Authority
PE
Peru
Prior art keywords
dihydroxyphenyl
methylpropyl
phenyl
compounds
alkyl
Prior art date
Application number
PE2005000320A
Other languages
Spanish (es)
Inventor
David Anthony Price
Charlotte Alice Louise Lane
Alan Daniel Brown
Kim James
Mark Edward Bunnage
Russell Andrew Lewthwaite
Paul Alan Glossop
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0420867A external-priority patent/GB0420867D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PE20051157A1 publication Critical patent/PE20051157A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Abstract

REFERIDA A COMPUESTOS DE FORMULA (1) DONDE (CH2)n-C(=O)Q1 ESTA EN POSICION META O PARA; R1 Y R2 SON CADA UNO H, ALQUILO C1-C4; n ES 0-2; Q1 ES *-NR8-Q2-A, *-NR8-Q3, ENTRE OTROS; Q2 ES ENLACE SENCILLO, ALQUILENO C1-C4 SUSTITUIDO O NO; R8 ES H, ALQUILO C1-C4; Q3 ES ALQUILO C1-C6 SUSTITUIDO O NO; A ES CICLOALQUILO C3-C10, HETEROCICLO DE 5-6 MIEMBROS, QUINOLILO, ENTRE OTROS; * ES EL PUNTO DE UNION AL GRUPO CARBONILO. SON COMPUESTOS PREFERIDOS: N-BENCIL-2-[3-(2-{[2-(3,5-DIHIDROXIFENIL)-2-HIDROXIETIL]AMINO}-2-METILPROPIL)FENIL]ACETAMIDA; 2-[3-(2-{[2-(3,5-DIHIDROXIFENIL)-2-HIDROXIETIL]AMINO}-2-METILPROPIL)FENIL]ACETAMIDA Y 2-(3-{2-[2-(3,5-DIHIDROXIFENIL)-2-HIDROXIETILAMINO]-2-METILPROPIL}FENIL)-1-(4-PIRIDIN-2-ILPIPERAZIN-1-IL)ETANONA; ENTRE OTROS. DICHOS COMPUESTOS SON UTILES PARA TRATAR AFECCIONES INFLAMATORIAS, ALERGICAS Y RESPIRATORIASREFERRED TO COMPOUNDS OF FORMULA (1) WHERE (CH2) n-C (= O) Q1 IS IN A GOAL OR FOR POSITION; R1 AND R2 ARE EACH H, C1-C4 ALKYL; n IS 0-2; Q1 IS * -NR8-Q2-A, * -NR8-Q3, AMONG OTHERS; Q2 IS SINGLE LINK, C1-C4 ALKYLENE REPLACED OR NOT; R8 IS H, C1-C4 ALKYL; Q3 IS C1-C6 ALKYL SUBSTITUTED OR NOT; A IS C3-C10 CYCLOALKYL, 5-6 MEMBER HETERO CYCLE, QUINOLYL, AMONG OTHERS; * IT IS THE POINT OF JOINT TO THE CARBONILO GROUP. PREFERRED COMPOUNDS ARE: N-BENZYL-2- [3- (2 - {[2- (3,5-DIHYDROXYPHENYL) -2-HYDROXYETHYL] AMINO} -2-METHYLPROPYL) PHENYL] ACETAMIDE; 2- [3- (2 - {[2- (3,5-DIHYDROXYPHENYL) -2-HYDROXYETHYL] AMINO} -2-METHYLPROPYL) PHENYL] ACETAMIDE AND 2- (3- {2- [2- (3,5 -DIHYDROXYPHENYL) -2-HYDROXYETHYLAMINE] -2-METHYLPROPYL} PHENYL) -1- (4-PYRIDIN-2-ILPIPERAZIN-1-IL) ETHANONE; AMONG OTHERS. SUCH COMPOUNDS ARE USEFUL TO TREAT INFLAMMATORY, ALLERGIC AND RESPIRATORY CONDITIONS

PE2005000320A 2004-03-23 2005-03-21 DIHYDROXYPHENYL-ETHYLAMINE DERIVATIVES AS ß2 AGONISTS PE20051157A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290769 2004-03-23
US59178904P 2004-07-27 2004-07-27
GB0420867A GB0420867D0 (en) 2004-09-21 2004-09-21 Compounds for the treatment of diseases
US62550504P 2004-11-05 2004-11-05

Publications (1)

Publication Number Publication Date
PE20051157A1 true PE20051157A1 (en) 2006-01-28

Family

ID=34961987

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000320A PE20051157A1 (en) 2004-03-23 2005-03-21 DIHYDROXYPHENYL-ETHYLAMINE DERIVATIVES AS ß2 AGONISTS

Country Status (15)

Country Link
JP (1) JP2008174555A (en)
KR (1) KR20070026425A (en)
AP (1) AP2006003728A0 (en)
AR (1) AR048323A1 (en)
DE (1) DE602005014624D1 (en)
EC (1) ECSP066832A (en)
IL (1) IL177531A0 (en)
MA (1) MA28482B1 (en)
NL (1) NL1028600C2 (en)
NO (1) NO20064805L (en)
PA (1) PA8627101A1 (en)
PE (1) PE20051157A1 (en)
SV (1) SV2006002059A (en)
TW (1) TW200536521A (en)
UY (1) UY28816A1 (en)

Also Published As

Publication number Publication date
KR20070026425A (en) 2007-03-08
DE602005014624D1 (en) 2009-07-09
SV2006002059A (en) 2006-02-15
UY28816A1 (en) 2005-10-31
PA8627101A1 (en) 2005-11-25
MA28482B1 (en) 2007-03-01
AR048323A1 (en) 2006-04-19
ECSP066832A (en) 2006-11-24
NO20064805L (en) 2006-12-01
IL177531A0 (en) 2006-12-10
JP2008174555A (en) 2008-07-31
AP2006003728A0 (en) 2006-10-31
NL1028600C2 (en) 2006-03-06
NL1028600A1 (en) 2005-09-26
TW200536521A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
PE20051136A1 (en) SULFONAMIDE DERIVATIVES
PE20091408A1 (en) COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
PE20050765A1 (en) SULFONAMIDE DERIVATIVES AS AGONISTS OF ß2 ADRENERGIC RECEPTORS
PE20121506A1 (en) TRIAZOLOPYRIDINE COMPOUNDS AS C-MET INHIBITORS
PE20050628A1 (en) 2-AMINO-PYRIDINE DERIVATIVES AS ß-2 AGONISTS
PE20120345A1 (en) DERIVATIVES OF 2- (1H-PIRROLO [2,3-B] PYRIDIN-5-ILOXI) -N-FENYLSULFONYLBENZAMIDE AS INHIBITORS OF ANTI-APOPTOTIC PROTEINS
PE20071156A1 (en) COMPOUNDS DERIVED FROM 4,5,6,7-TETRAHYDRO-1H-INDAZOLE AS ENHANCERS OF THE a-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR (AMPA)
PE20120814A1 (en) COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
PE20120655A1 (en) TRIAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINES ACTIVATED BY MITOGEN P38 (MAP)
ECSP10010157A (en) FUNGICIDE COMPOSITION AND METHOD FOR THE CONTROL OF HARMFUL FUNGI
PE20070347A1 (en) N-THIO-ANTRANYLAMIDE COMPOUNDS AS PESTICIDE AGENTS
PE20060554A1 (en) SALICILTIAZOLES SUBSTITUTED WITH DIPHENYLAMINE OR DERIVATIVES OF DIPHENYLAMINE AS INHIBITORS OF PHOSPHOTHYROSINE PHOSPHATASE 1B AND PROCEDURES FOR THEIR PREPARATION
PE20110028A1 (en) DERIVATIVES OF ISOXAZOLE AND THEIR USE AS ENHANCERS OF METABOTROPIC GLUTAMATE RECEPTORS
PE20080315A1 (en) DERIVATIVES OF PIRAZOLO- [3,4-d] -PYRIMIDINES AS INHIBITORS OF KINASE PI-3
PE20061117A1 (en) DERIVATIVES OF PHENYLGLYCINAMIDE AS INHIBITORS OF FACTOR VIIa
CO6170361A2 (en) COMPOSITIONS AND METHODS TO MODULATE C-KIT AND PDGFR RECEPTORS
PE20090434A1 (en) SULFONIL AMIDE DERIVATIVES AS KINASE INHIBITORS
PE20050142A1 (en) BENZAMIDE 2-HYDROXY-3-DIAMINOALKANES
PE20091952A1 (en) TIAZOLE AND OXAZOLE COMPOUNDS OF BENZENE SULFONAMIDE
PE20070189A1 (en) AMINO-5-HETEROARYL COMPOUND (5 MEMBERS) IMIDAZOLONE AND ITS USE FOR ß-SECRETASE MODULATION
AR078944A1 (en) N1-PIRAZOLOESPIROCETONA ACETIL-COA CARBOXYLASE INHIBITORS
PE20091370A1 (en) INSECTICIDE ARYLPYRROLINS
UY30540A1 (en) INSECTICIDE ISOXAZOLINS
PE20081544A1 (en) BENZOTHIAZOLONE DERIVATIVES AS BETA AGONISTS
PE20121085A1 (en) 17-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9 (10) -DIEN-11-ARYL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND USE FOR THE TREATMENT OF DISEASES

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed